Conventional and First Derivative Synchronous Fluorometric Determination of Ethamsylate in Pharmaceutical Preparations and Biological Fluids. Application to Stability Studies
- 164 Downloads
Two simple, accurate and highly sensitive spectrofluorometric methods were developed for the determination of ethamsylate (ETM). Method I is based on measuring the native fluorescence of ethamsylate in water at 354 nm after excitation at 302 nm. The calibration plot was rectilinear over the range of 0.05–1 μg/mL for ETM with limits of detection and quantitation of 7.9 and 26 ng/mL, respectively. Method II involved synchronous and first derivative synchronous fluorometric methods for the simultaneous determination of ethamsylate (ETM) and hydroquinone (HQ) which is considered as an impurity and/or acidic degradation product. The synchronous fluorescence of both the drug and its impurity were measured in methanol at Δ λ of 40 nm. The peak amplitudes (1D) were estimated at 293.85 or 334.17 nm for ETM and at 309.05 nm for HQ. Good linearity was obtained for ETM over the ranges 0.1–1.4 μg/mL and 0.1–1.0 μg/mL at 293.85 and 334.17 nm, respectively. For HQ, the calibration plot was rectilinear over the range of 0.01–0.14 μg/mL at 309.05 nm. Limits of detection were 20, 2.01 ng/mL and limits of quantitation were 60, 6.7 ng/mL for ETM and HQ by method II, respectively. Both methods were successfully applied to commercial ampoules and tablets. The results were in good agreement with those obtained by the reference method. Method I was utilized to study the stability of ETM and its degradation kinetics using peroxide. The apparent first-order rate constant, half-life times and activation energy of the degradation process were calculated. Method I was further extended to the in-vitro and in-vivo determination of ETM in spiked and real plasma samples. The mean% recoveries were 99.57 ± 3.85 and 89.39 ± 5.93 for spiked and real human plasma, respectively.
KeywordsEthamsylate Hydroquinone Synchronous fluorimetry Human plasma Stability study Degradation-kinetics
- 1.Sweetman SC (ed) (2007) Martindale, the complete drug reference, 35th edn. Pharmaceutical Press, London, p 959Google Scholar
- 2.The British Pharmacopoeia (2007) The Stationery Office: London; Electronic versionGoogle Scholar
- 8.Xu ZC, Li XY, Shi J, Yao XJ, Liu AZ, He ZS (1994) Determination of Dicynone [ethamsylate] in gastric mucosa by ultra-violet spectrophotometry. Fenxi Huaxue 22(4):420Google Scholar
- 11.Ma J, Liu Y (1984) Quantitative analysis of etamsylate by h.p.l.c. Yaowu Fenxi Zazhi 4(4):209–211Google Scholar
- 13.Wang ZH, Li ZG, Zhou SP (2005) Voltammetric behavior of embedded super-thin carbon film electrode and its application. Fenxi Huaxue 33(4):523–526Google Scholar
- 15.Wang ZH, Zhang D, Zhang Y, Zhou SP (2001) Voltammetric behaviour of Dicynone at a poly(4-aminopyridine) film-modified electrode and its determination by adsorptive stripping voltammetry. Fenxi Huaxue 29(1):83–86Google Scholar
- 17.Li YH, Du JX, Lu JR (2002) Chemiluminescence reaction of luminol-[potassium ferricyanide-potassium ferrocyanide]-ethamsylate system. Fenxi Huaxue 30(6):742–744Google Scholar
- 19.Zhang CX, Huang JC, Feng ML, Zhang ZJ (1998) Flow injection chemiluminescence determination of etamsylate with electrogenerated hypochlorite. Anal Lett 31(11):1917–1928Google Scholar
- 21.Skoog DA, Holler FJ, Crouch SR (2007) Principles of instrumental analysis, 6th edn. Thomson, Belmont, p 406Google Scholar
- 22.Miller JN, Miller JC et al (2005) Statistics and chemometrics for analytical chemistry. Pearson Education Limited, Harlow, pp 39–73, 107–149, 256Google Scholar
- 23.ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 1996, Incorporated in November 2005. http://www.ich.org/LOB/media/MEDIA417.pdf (accessed February 15, 2008).
- 26.Martin A, Bustamante P (1993) Physical pharmacy, 4th edn. Lea and Febiger, Pheladelphia, p 295Google Scholar